Immunoprecipitation Market Research Report - Forecast till 2030

Immunoprecipitation Market Research Report Information by Type (Individual Immunoprecipitation, Co-Immunoprecipitation, Chromatin Immunoprecipitation, and RNA Immunoprecipitation), Product (Kit, Reagent, others), End-User (CROs, others) - Forecast till 2030

ID: MRFR/HC/6346-HCR | 90 Pages | Author: Rahul Gotadki | December 2023         

Immunoprecipitation Market Speak to Analyst Request a Free Sample

Immunoprecipitation Market

Immunoprecipitation market is expecte dto grow USD 820 Million at a CAGR 5.30% during the forecast period 2022-2030.

By Type Individual Immunoprecipitation Co-Immunoprecipitation Chromatin Immunoprecipitation RNA Immunoprecipitation
By Product Kit Reagent Others
Key Players
Companies Profiled   Abcam plc   GenScript   Thermo Fisher Scientific   Bio-Rad Laboratories Inc.   Merck KGaA   BioLegend Inc.   Takara Bio Inc.   Rockland Immunochemicals Inc.   Cell Signaling Technology Inc.   Geno Technology Inc.
Market Driving Forces   Increasing demand to find definitive cures for autoimmune and other immune diseases
Request a Free Sample

Immunoprecipitation Market OverviewThe immunoprecipitation Market will notice significant growth over the forecast period. It will obtain a value of USD 820 Million and register a CAGR of 5.30 % by 2030.  The developmental activities like collaborations between researchers and organizations are significantly resulting life science sector’s growth. Scientific advancement in cellular and genetic therapies led to new techniques driving the market. The rise in research activities in immunotherapy, genomics, and the microbiome leads to market expansion.  The development of modern genetic techniques with the growth in the research and development activities of genomics for diseases study, designing, and rug development will accelerate the market. Many federal bodies taking strategic initiatives for genomic research enhance the healthcare sector, which is further driving the market. The heavy investment in R&D activities, to a large extent, is aiding the market. Genomic-based research activities will generate the need for more investments for which they are supporting the market. The focus on ]n areas such as oncology, immunology, and immuno-oncology also leads to the market’s growth. Technological advancements in immunoprecipitation techniques will propel the market’s demand. Advancement in chromatin immunoprecipitation technique leads to a bead-free method of chromatin immunoprecipitation, known as Chromatrap Immunoprecipitation (ChIP) technology. Epigenetic advancements with ChIP-seq will set wide opportunities for the market.

Market Segmentation

The global immunoprecipitation market has been segmented into type, product, end user, and region.

The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.

The market, by type, has been segmented into kit, reagent, and others.

The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.

The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The immunoprecipitation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The immunoprecipitation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The immunoprecipitation market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

  • Abcam plc

  • GenScript

  • Thermo Fisher Scientific

  • Bio-Rad Laboratories, Inc.

  • Merck KGaA

  • BioLegend, Inc.

  • Takara Bio Inc.

  • Rockland Immunochemicals Inc.

  • Cell Signaling Technology, Inc.

  • Geno Technology Inc.

Regional Summary

 Global Immunoprecipitation Market Share (%), by Region, 2017  Immunoprecipitation Market

Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)

Geographically, the Americas is anticipated to dominate the global market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the American immunoprecipitation market.

Europe is expected to hold the second-largest position in the global market. The market growth in this region is attributed to the availability of funds for research.

Asia-Pacific is anticipated to be the fastest-growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics. On the other hand, the Middle East & Africa is expected to account for the least share of the market. 

Global Immunoprecipitation Market, by Type

  • Individual Immunoprecipitation

  • Co-Immunoprecipitation

  • Chromatin Immunoprecipitation

  • RNA Immunoprecipitation

Global Immunoprecipitation Market, by Product

  • Kit

  • Reagent

    • Primary

    • Secondary

    • Agarose Beads

    • Magnetic Beads

    • Buffers

    • Antibodies

    • Beads

    • Others

Global Immunoprecipitation Market, by End User

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations

  • Others

Global Immunoprecipitation Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • South America

  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Middle East

    • Africa

Recent Development

In May 2022

The Co-Immunoprecipitation Kits report contains the data that depicts numerous growth opportunities, growth possibilities, upcoming market threats, past development patterns, additional potential evaluations, market projections, and many others. This data information is presented for promoting wise and continuous improvement. It also comprises several tactics and processes to aid in segregating a market into smaller segments for evaluating the impact of the market industry in different regions of the world. It also underlines the necessity and demand for Co-Immunoprecipitation Kits in the entire business industry.Intended Audience

  • Biotechnology Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 820 Million
  CAGR   5.30%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Product, End user, and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc.
  Key Market Opportunities   Research activities in the life sciences sector
  Key Market Drivers   Increasing demand to find definitive cures for autoimmune and other immune diseases.

Frequently Asked Questions (FAQ) :

The global immunoprecipitation market is expected to hold a market valuation of USD 820 Million over the forecast period from 2022-2030.

The global immunoprecipitation market is expected to exhibit a strong 5.30% CAGR over the forecast period from 2022-2030.

The increasing demand to find definitive cures for autoimmune and other immune diseases is the major driver for the market.

The Americas and Europe are likely to remain the dominant regional markets over the forecast period.

Leading players in the global immunoprecipitation market include GenScript, Merck, Bio-Rad, Thermo Fisher Scientific, and others.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response